TOP TIERMARKET NEWSWIRE
SEC Form 4 history

BICARA THERAPEUTICS Equity (BCAX) insider trades

BICARA THERAPEUTICS Equity (BCAX) insider trading activity (SEC Form 4). Over the trailing 90 days, BCAX insiders filed 0 purchases totalling $0 and 7 sales totalling $3.5M — net SELLING of $3.5M. Most recent filing: Sep 10, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
7
$3.5M
Net (90d)
-$3.5M
net selling
Most recent
Sep 10, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 10, 2026Cohlhepp RyanPres, COO, Interim CEOS SaleOE—$22.90$401Kfiling
Aug 12, 2026Cohlhepp RyanPres, COOS SaleOE—$27.98$525Kfiling
Aug 12, 2026Mazumdar ClaireCEOS SaleOE—$27.98$280Kfiling
Aug 12, 2026Hyep IvanCFOS SaleOE—$27.97$350Kfiling
Jul 14, 2026Mazumdar ClaireCEOS SaleOE—$28.42$284Kfiling
Jul 10, 2026Cohlhepp RyanPres, COOS SaleOE—$28.98$833Kfiling
Jul 10, 2026Hyep IvanCFOS SaleOE—$28.85$808Kfiling
May 26, 2026Hyep IvanCFOS SaleOE—$20.42$188Kfiling
May 18, 2026Cohlhepp RyanPres, COOS SaleOE—$20.29$254Kfiling